1. Home
  2. IVDA vs BGLC Comparison

IVDA vs BGLC Comparison

Compare IVDA & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iveda Solutions Inc.

IVDA

Iveda Solutions Inc.

N/A

Current Price

$0.29

Market Cap

3.7M

Sector

Technology

ML Signal

N/A

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$1.61

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IVDA
BGLC
Founded
2003
2017
Country
United States
Malaysia
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
4.3M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
IVDA
BGLC
Price
$0.29
$1.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.4M
9.4K
Earning Date
05-12-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
51.38
45.78
EPS
N/A
N/A
Revenue
$4,468,279.00
$7,424,911.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
132.98
N/A
52 Week Low
$0.21
$1.07
52 Week High
$2.24
$6.10

Technical Indicators

Market Signals
Indicator
IVDA
BGLC
Relative Strength Index (RSI) 45.80 42.89
Support Level $0.27 $1.23
Resistance Level $0.34 $1.88
Average True Range (ATR) 0.03 0.12
MACD -0.00 -0.00
Stochastic Oscillator 25.08 32.81

Price Performance

Historical Comparison
IVDA
BGLC

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products). Geographically, the company operates in USA and Taiwan, majority of its revenue is generated from Taiwan.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

Share on Social Networks: